Your session is about to expire
← Back to Search
Peer Support Program for Chronic Pain (PEEPS Trial)
N/A
Waitlist Available
Led By Sara Edmond, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has high-impact chronic pain as defined by the Graded Chronic Pain Scale - Revised
Be older than 18 years old
Must not have
Moderate to severe cognitive impairment or apparent difficulty communicating with the research staff
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how peer specialists can help Veterans with chronic pain manage it to improve quality of life.
Who is the study for?
This trial is for Veterans with chronic pain who are part of the VA Connecticut Healthcare System and have been referred to a Pain Management Team. Participants must experience high-impact chronic pain, be able to attend sessions in person or via video, but can't join if they have severe cognitive issues, communication difficulties, or impaired hearing/speech.
What is being tested?
The study is testing a peer-led intervention called PEEPS designed to help Veterans manage their chronic pain better. It aims to enhance function, increase physical activity, and encourage engagement in recommended pain care through support from trained peers with similar experiences.
What are the potential side effects?
Since this trial involves peer support rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience emotional discomfort when discussing personal experiences related to their chronic pain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have severe, long-term pain.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have significant trouble thinking or communicating with others.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, approximately 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability
Feasibility - Number of completers
Secondary study objectives
Acceptability - Quantitative
Feasibility - Enrollment of >15% of those invited
Feasibility - Recruiting 24 participants
+1 moreOther study objectives
Healthcare engagement
Pain Interference
Pain self-management
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: peer specialistExperimental Treatment1 Intervention
Work with a peer specialist for six 30-minute sessions
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,572 Total Patients Enrolled
42 Trials studying Chronic Pain
5,147 Patients Enrolled for Chronic Pain
Sara Edmond, PhDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have significant trouble thinking or communicating with others.I have severe, long-term pain.You have been referred to a pain management team at VA Connecticut.
Research Study Groups:
This trial has the following groups:- Group 1: peer specialist
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger